Comparison of web-based information about cell-free DNA prenatal screening: implications for differences of sex development care
ObjectiveCell-free DNA (cfDNA) prenatal screening is a commercially available noninvasive test that detects fetal genetic material in maternal blood. While expectant parents often use it for “gender” determination, there is little information about unintended consequences of testing, such as revelat...
Main Authors: | Soojin Kim, Esther L. Finney, Ushasi Naha, Ilina Rosoklija, Kyle S. Honegger, Allison Goetsch Weisman, Jane L. Holl, Courtney Finlayson, Diane Chen, Emilie K. Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Urology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fruro.2023.1144618/full |
Similar Items
-
Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report
by: Nuria Balaguer, et al.
Published: (2021-01-01) -
Fetal sex discordance
by: Álvaro López Soto, et al.
Published: (2020-09-01) -
Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01) -
Improved noninvasive fetal variant calling using standardized benchmarking approaches
by: Tom Rabinowitz, et al.
Published: (2021-01-01) -
Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey
by: Wilson V. Chan, et al.
Published: (2018-01-01)